Whose germplasm is it?

NBA struggles to frame case against Mahyco in first biopiracy case

Gunning for green tech

US continues to target India over its intellectual property regime, especially in pharma, green tech sectors

What's with this Kolaveri about John Doe injunctions?

In jurisdictions where the law of copyright is much more matured as compared to India, the injunctions are issued very judiciously, and by …

Gopal Subramaniam, Rohinton Nariman swap places in Novartis patent case

 Will take on each other in the patent case of anti-cancer drug Glivec filed by Novartis

Choking access to drugs

Drug prices are likely to increase as rich countries and their pharma companies squeeze Indian generics out of the market. How can India’s …

Future compromised

The Earth Summit was a historical opportunity to set the world on the correct development trajectory. Negotiators from 191 countries came …

Patent hypocrisies of US

American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards

Any cheers for Doha pact?

The Doha Declaration on protecting public health is a decade old, but developing countries have not been able to make use of TRIPs flexibilities

No climate for cleantech

Most of the clean energy innovations are with just six rich countries and hardly any technology is coming to developing nations

Caution: pastures ahead

Costly silence

No one is debating where goats will graze

A lethal secrecy in trade deals

Why do democratic governments hide trade negotiations that have dire consequences for public services?

Pursuing a nationalist IPR policy

India has enough laws to protect its intellectual property rights. It is the implementation that is wanting

The pirates come ashore

German Pirate Party’s strong showing in the May elections is a sign that anti-IPR movements resonate with the people

Patent issues delaying Ebola cure

Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine

ACTA fury goes viral

Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar

Sub-standard drugs bigger problem than counterfeit drugs: health activists

Problem of poor quality drugs cannot be solved with technology alone, they say

Say cheese to Brussels

Global report on challenges faced by seed sector launched

Focuses on need to stop seed laws that are preventing farmers from saving and exchanging their indigenous varieties  

What Durban did not discuss

IPRs are blocking access to mitigation and adaptation technologies. India offers a way out

New endosulfan ploy

Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global

Return of village land

Supreme Court asks states to evict illegal occupants of village commons

Letters

WTO gives India a clean chit

Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review